Health  Vol.8 No.4 , February 2016
Relationship between Serum Visfatin and Obesity in Lead-Exposed Obese Subjects and Patients with Osteoarthritis
Abstract: Aim: To evaluate the relationship between serum levels of visfatin, lead (PB) and cadmium (Cd) in obese male subjects with osteoarthritis (OA). Methods: A total of 40 obese males (age: 25 - 55 years; BMI ≥ 30) participated in the study. They were subdivided into 3 groups; group A, 10 patients with OA; group B, 15 workers in gasoline filling stations; group C, 15 obese subjects without any apparent other health problems or chronic diseases. After overnight fasting, blood samples were collected from all participants to evaluate blood levels of Pb, Cd and HbA1c, in addition to serum visfatin, lipid profile, glucose and total antioxidant state (TAS). Results: Obese patients with OA have significantly higher BMI value (p < 0.05) than the other groups. Obese gasoline station workers demonstrate highest blood lead levels compared to the other groups. Serum visfatin levels in obese subjects with OA were significantly higher than that reported in the other groups. Blood lead contents and serum visfatin levels were positively and significantly correlated in the three groups, and greatest correlation coefficient value (r) was reported in obese OA patients followed by obese gasoline station workers and healthy obese subjects, respectively. BMI in obese healthy subjects shows weak positive and non-significant relationship with serum visfatin levels, while highly positive and significant correlation was reported between these two markers in obese gasoline station workers. However, BMI values and serum visfatin showed weak negative and non-significant correlation with serum visfatin levels in obese OA patients. Conclusion: Serum visfatin levels could be key regulators of obesity and OA, and an important partner with excessive environmental exposure to Pb in the pathogenesis of these disorders.
Cite this paper: Numan, A. , Al-Joda, A. and Jawad, N. (2016) Relationship between Serum Visfatin and Obesity in Lead-Exposed Obese Subjects and Patients with Osteoarthritis. Health, 8, 318-324. doi: 10.4236/health.2016.84033.

[1]   Mahjoub, M., Berenbaum, F. and Houard, X. (2012) Why Subchondral Bone in Osteoarthritis? The Importance of the Cartilage Bone Interface in Osteoarthritis. Osteoporosis International, 23, S841-S846.

[2]   Goldring, S.R. (2012) Alterations in Periarticular Bone and Cross Talk between Subchondral Bone and Articular Cartilage in Osteoarthritis. Therapeutic Advances in Musculoskeletal Diseases, 4, 249-258.

[3]   Loeser, R.F., Goldring, S.R., Scanzello, C.R. and Goldring, M.B. (2012) Osteoarthritis: A Disease of the Joint as an Organ. Arthritis and Rheumatism, 64, 1697-1707.

[4]   Mutabaruka, M.S., Aoulad Aissa, M., Delalandre, A., Lavigne, M. and Lajeunesse, D. (2010) Local Leptin Production in Osteoarthritis Subchondral Osteoblasts May Be Responsible for Their Abnormal Phenotypic Expression. Arthritis Research and Therapy, 12, R20.

[5]   Gomez, R., Conde, J., Scotece, M., Gomez-Reino, J.J., Lago, F. and Gualillo, O. (2011) What’s New in Our Understanding of the Role of Adipokines in Rheumatic Diseases? Nature Reviews Rheumatology, 7, 528-536.

[6]   Gabay, O. and Berenbaum, F. (2009) Adipokines in Arthritis: New Kids on the Block. Current Rheumatology Reviews, 5, 226-232.

[7]   Bijlsma, J.W., Berenbaum, F. and Lafeber, F.P. (2011) Osteoarthritis: An Update with Relevance for Clinical Practice. Lancet, 377, 2115-2126.

[8]   Luk, T., Malam, Z. and Marshall, J.C. (2008) Pre-B Cell Colony-Enhancing Factor (PBEF)/Visfatin: A Novel Mediator of Innate Immunity. Journal of Leukocyte Biology, 83, 804-816.

[9]   Gosset, M., Berenbaum, F., Salvat, C., Sautet, A., Pigenet, A., Tahiri, K. and Jacques, C. (2008) Crucial Role of Visfatin/Pre-B Cell Colony-Enhancing Factor in Matrix Degradation and Prostaglandin E2 Synthesis in Chondrocytes: Possible Influence on Osteoarthritis. Arthritis and Rheumatism, 58, 1399-1409.

[10]   Moschen, A.R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H. and Tilg, H. (2007) Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties. Journal of Immunology, 178, 1748-1758.

[11]   Faulk, C., Barks, A., Sanchez, B.N., Zhang, Z., Anderson, O.S., et al. (2014) Perinatal Lead (Pb) Exposure Results in Sex-Specific Effects on Food Intake, Fat, Weight, and Insulin Response across the Murine Life-Course. PLoS ONE, 9, e104273.

[12]   Carmouche, J.J., Edward Puzas, J., Zhang, X., Tiyapatanaputi, P., Cory-Slechta, D.A., Robert Gelein, R., et al. (2005) Lead Exposure Inhibits Fracture Healing and Is Associated with Increased Chondrogenesis, Delay in Cartilage Mineralization, and a Decrease in Osteoprogenitor Frequency. Environmental Health Perspectives, 113, 749-755.

[13]   ACR (2000) Recommendations for the Medical Management of Osteoarthritis of the Hip and Knee. Arthritis and Rheumatism, 43, 1905-1915.<1905::AID-ANR1>3.0.CO;2-P

[14]   Leng, S., McElhaney, J., Walston, J., Xie, D., Fedarko, N. and Kuchel, G. (2008) Elisa and Multiplex Technologies for Cytokine Measurement in Inflammation and Aging Research. Journal of Gerontology: Biological and Medical Sciences, 63, 879-884.

[15]   Erel, O. (2004) A Novel Automated Direct Measurement Method for Total Antioxidant Capacity Using a New Generation, More Stable ABTS Radical Cation. Clinical Biochemistry, 37, 277-285.

[16]   Fossati, P. and Prencipe, L. (1982) Measurement of Serum TG Colorimetrically with an Enzyme That Produce H2O2. Clinical Chemistry, 28, 2077-2080.

[17]   Burstein, M., Scholink, H.R. and Morfin, R. (1970) Measurement of HDL-c in the Plasma with a Sensitive Colorimetric Method. Journal of Lipid Research, 19, 583.

[18]   Trinder, P. (1969) Determination of Blood Glucose Using an Oxidase-Peroxidase System with a Non-Carcinogenic Chromogen. Journal of Clinical Pathology, 22, 158-161.

[19]   Weykamp, C., John, W.G. and Mosca, A. (2009) A Review of the Challenge in Measuring Hemoglobin A1c. Journal of Diabetes Science and Technology, 3, 439-445.

[20]   Subramanian, K.S. and Meranger, J.C. (1981) A Rapid Electro-thermal Atomic Absorption Spectrophotometric Method for Cadmium and Lead in Human Whole Blood. Clinical Chemistry, 27, 1866-1871.

[21]   van der Helm-van Mil, A.H., van der Kooij, S.M., Allaart, C.F., Toes, R.E. and Huizinga, T.W. (2008) A High Body Mass Index Has a Protective Effect on the Amount of Joint Destruction in Small Joints in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 67, 769-674.

[22]   Gross, A.F., Fickert, S. and Gunther, K.P. (2005) Obesity and Arthritis. Orthopade, 34, 638-644.

[23]   Felson, D.T., Anderson, J.J., Naimark, A., Walker, A.M. and Meenan, R.F. (1988) Obesity and Knee Osteoarthritis. The Framingham Study. Annals of Internal Medicine, 109, 18-24.

[24]   Griffin, T.G., Huebner, J.L., Kraus, V.B., et al. (2012) Induction of Osteoarthritis and Metabolic Inflammation by a Very High-Fat Diet in Mice. Arthritis and Rheumatism, 64, 443-453.

[25]   Aspden, R.M. (2011) Obesity Punches above Its Weight in Osteoarthritis. Nature Reviews Rheumatology, 7, 65-68.

[26]   Mahmood, N.M.A. (2012) Relationship between Exposure to Petrol Products and the Trace Metal Status, Liver Toxicity and Hematological Markers in Gasoline Filling Workers in Sulaimani City. Journal of Environmental and Occupational Science, 1, 6-11.

[27]   Agrawal, S., Bhatnagar, P. and Flora, S.J. (2015) Changes in Tissue Oxidative Stress, Brain Biogenic Amines and Acetylcholinesterase Following Co-Exposure to Lead, Arsenic and Mercury in Rats. Food Chemistry and Toxicology, 86, 208-216.

[28]   Kawai, Y., Kubota, E. and Okabe, E. (2000) Reactive Oxygen Species Participation in Experimentally Induced Arthritis of the Temporomandibular Joint in Rats. Journal of Dental Research, 79, 1489-1495.

[29]   Ghanwat, G.H., Patil, A.J., Patil, J.A., Kshirsagar, M.S., Sontakke, A. and Ayachit, R.K. (2015) Biochemical Effects of Lead Exposure on Oxidative Stress and Antioxidant Status of Battery Manufacturing Workers of Western Maharashtra, India. Journal of Basic and Clinical Physiology and Pharmacology, Published Online.

[30]   Shlopov, B.V., Gumanovskaya, M.L. and Hasty, K.A. (2000) Autocrine Regulation of Collagenase 3 (Matrix Metalloproteinase 13) during Osteoarthritis. Arthritis and Rheumatism, 43, 195-205.<195::AID-ANR24>3.0.CO;2-G